Blood and neoplastic diseases. Myelomatosis.
D001809:Blood Viscosity; D001847:Bone Diseases / Q000209:etiology / Q000517:prevention & control; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology; D008558:Melphalan / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D009194:Myeloma Proteins / Q000096:biosynthesis; D010146:Pain / Q000209:etiology; D010710:Phosphates / Q000627:therapeutic use; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D009194:Myeloma Proteins; D010710:Phosphates; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D008558:Melphalan; D005459:Fluorides